CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $10.27B, above the global median of $1.18B
- PositionP/E ratio is 252.15×, higher than 95% of its Medical Instruments & Supplies peers (median 33.04×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.27BUSDvs all stocks (USD)
Trailing P/E
252.15xvs Medical Instruments & Supplies peers
Revenue (TTM)
785.10MUSDvs all stocks (USD)
Profit Margin
5.29%vs Medical Instruments & Supplies peers
Beta
1.01xvs all stocks
52-Week Change
48.81%vs all stocks
Market Capitalization
10.27BUSDvs all stocks (USD)
Enterprise Value
10.06BUSDvs all stocks (USD)
Trailing P/E
252.15xvs Medical Instruments & Supplies peers
Forward P/E
68.79xvs Medical Instruments & Supplies peers
PEG Ratio
-3.86xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
13.05xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
4.85xvs Medical Instruments & Supplies peers
Enterprise to Revenue
12.81xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
69.78xvs Medical Instruments & Supplies peers
Gross Margin
53.91%vs Medical Instruments & Supplies peers
Profit Margin
5.29%vs Medical Instruments & Supplies peers
Operating Margin
9.31%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.40%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.99%vs Medical Instruments & Supplies peers
Revenue (TTM)
785.10MUSDvs all stocks (USD)
Revenue per Share (TTM)
13.94USDUpdated Aug 28, 2026Quarterly Revenue Growth
11.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
422.67MUSDvs all stocks (USD)
EBITDA (TTM)
159.53MUSDvs all stocks (USD)
Net Income (TTM)
41.54MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-66.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
134.86MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
113.42MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
738.26MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
352.01MUSDFY2025 · Dec 31, 2025Gross Profit
386.25MUSDFY2025 · Dec 31, 2025Operating Income
41.56MUSDvs all stocks (USD)
Pre-tax Income
62.38MUSDFY2025 · Dec 31, 2025Income Tax Expense
13.49MUSDFY2025 · Dec 31, 2025Net Income
48.89MUSDFY2025 · Dec 31, 2025EBIT
83.90MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
139.67MUSDFY2025 · Dec 31, 2025Research & Development
54.18MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
290.51MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
21.51MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.8700USDFY2025 · Dec 31, 2025EPS (Diluted)
0.8600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
56.23MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
56.23MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
48.89MUSDFY2025 · Dec 31, 2025Operating Cash Flow
113.36MUSDFY2025 · Dec 31, 2025Free Cash Flow
90.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
566.02MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
48.89MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
96.96MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-3.37MUSDFY2025 · Dec 31, 2025Stock-based Compensation
32.60MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-6.79MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-17.16MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-4.15MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-33.62MUSDFY2025 · Dec 31, 2025Capital Expenditures
-23.28MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025Net Acquisitions
-70.33MUSDFY2025 · Dec 31, 2025Purchase of Investments
-200.26MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
-2.40MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-296.26MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-18.38MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-18.38MUSDFY2025 · Dec 31, 2025Shares Outstanding
56.43MSharesUpdated Aug 28, 2026Float Shares
53.47MSharesUpdated Aug 28, 2026Shares Short
6.09MSharesUpdated Aug 28, 2026Short Ratio
4.86daysvs all stocks
Short % of Shares Outstanding
10.82%vs all stocks
% Held by Insiders
5.24%vs all stocks
% Held by Institutions
120.06%vs all stocks
Total Cash (MRQ)
810.45MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
14.36USDUpdated Aug 28, 2026Total Debt (MRQ)
690.94MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3271xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.05xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
37.43USDUpdated Aug 28, 2026Total Assets
2.95BUSDvs all stocks (USD)
Total Current Assets
1.14BUSDFY2025 · Dec 31, 2025Total Liabilities
843.57MUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.81BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
707.74MUSDFY2025 · Dec 31, 2025Total Current Liabilities
135.83MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
566.02MUSDFY2025 · Dec 31, 2025Other Short-term Investments
201.61MUSDFY2025 · Dec 31, 2025Accounts Receivable
158.59MUSDFY2025 · Dec 31, 2025Inventory
170.46MUSDFY2025 · Dec 31, 2025Accounts Payable
30.01MUSDFY2025 · Dec 31, 2025Short-term Debt
21.56MUSDFY2025 · Dec 31, 2025Deferred Revenue
14.61MUSDFY2025 · Dec 31, 2025Other Current Liabilities
5.05MUSDFY2025 · Dec 31, 2025Long-term Debt
668.39MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
16.86MUSDFY2025 · Dec 31, 2025Common Stock (Book)
563.00KUSDFY2025 · Dec 31, 2025Retained Earnings
456.25MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
2.11BUSDvs all stocks (USD)
52-Week Low
100.99USDUpdated Aug 28, 202652-Week High
188.73USDUpdated Aug 28, 202652-Week Change
48.81%vs all stocks
Beta
1.01xvs all stocks
50-Day MA
149.92USDUpdated Aug 28, 2026200-Day MA
141.14USDUpdated Aug 28, 2026Avg 10-Day Volume
950.65KSharesUpdated Aug 28, 2026Avg 30-Day Volume
1.22MSharesUpdated Aug 28, 2026Diluted EPS (TTM)
0.7200USDUpdated Aug 28, 2026Other Income / Expense
44.00MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How does this company use capital?
Cash-Backed Earnings Configuration
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 252.15×, higher than 95% of its Medical Instruments & Supplies peers (median 33.04×)Significant
P/E ratio: 252.153Industry median: 33.04Industry P95: 247.067Peers compared: 109
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.54Profit Margin: 0.05
Financial Health
Altman Z-Score 8.27: safe zoneNotable
Altman Z-Score: 8.27
High earnings qualityNotable
Earnings Quality Score: 0.90
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $10.27B, above the global median of $1.18BNotable
Market cap (USD): 10,272,976,034Global Median: 1,179,398,897.704
Revenue is $785.1M, above the global median of $534.05MNotable
Revenue (USD): 785,100,992Global Median: 534,052,387.958
Levered free cash flow is $113.42M, above the global median of $19.19MNotable
Levered free cash flow (USD): 113,421,752Global Median: 19,189,974.917
Companies that share the same coordination system — how they create, deliver, or capture value.
Shenzhen Megmeet Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Spx Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Puya Semiconductor (Shanghai) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Acuity Brands Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Advanced Drainage Systems, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Max Healthcare Institute Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Bharat Forge Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Konfoong Materials International Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Formosa Chemicals & Fibre Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cognex Corporation
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Funshine Culture Group Co., Ltd.
1 interpretationLiquidity Ratios Elevated
Intrepid Potash Inc.
2 interpretationsCash-Backed Earnings ConfigurationLiquidity Ratios Elevated
PJT Partners Inc.
1 interpretationLiquidity Ratios Elevated